MethylGene Inc.
7220 Frederick-Banting
Suite 200
Montreal
Quebec
H4S 2A1
Canada
Tel: 514-337-3333
Fax: 514-337-0550
Website: http://www.methylgene.com/
Email: info@methylgene.com
209 articles about MethylGene Inc.
-
Curis Expands Senior Management Expertise with Appointment of Robert Martell, M.D., Ph.D., as Head of Research and Development
5/24/2018
Curis, Inc. today announced that Robert Martell, M.D., Ph.D., has been appointed Head of Research and Development.
-
Mirati Therapeutics and MethylGene Announce Completion of Plan of Arrangement
6/28/2013
-
MethylGene Shareholders Approve the Plan of Arrangement to Reincorporate in the United States as Mirati Therapeutics Inc.
6/25/2013
-
MethylGene Presents Clinical Data on Mocetinostat at the 2013 American Society of Clinical Oncology Annual Meeting
6/3/2013
-
MethylGene to Present at the Jefferies and Co. 2013 Healthcare Conference
5/30/2013
-
MethylGene to Present Mocetinostat Data at the 2013 American Society of Clinical Oncology Annual Meeting
5/28/2013
-
MethylGene Reports First Quarter 2013 Financial Results
5/13/2013
-
MethylGene Announces Plan to Reincorporate in the United States as Mirati Therapeutics, Inc. and List on the NASDAQ
5/9/2013
-
MethylGene Presents Preclinical Data on MG516 at the American Association for Cancer Research Annual Meeting
4/8/2013
-
MethylGene Reports Results of Phase 2 Trial of MGCD290
3/18/2013
-
MethylGene Announces Management Changes
3/14/2013
-
MethylGene Reports Fourth Quarter and Full Year 2012 Financial Results
3/13/2013
-
MethylGene Announces the Appointment of Mark J. Gergen, as Executive Vice President and COO
2/19/2013
-
MethylGene Completes Enrollment in Phase 2 Trial of MGCD290
12/19/2012
-
MethylGene to Present at the Piper Jaffray 24th Annual Healthcare Conference
11/21/2012
-
MethylGene Closes $26.1 Million Private Placement
11/21/2012
-
MethylGene Reports Third Quarter 2012 Financial Results and Provides Corporate Update
11/14/2012
-
MethylGene Appoints Dr. Charles M. Baum to President and CEO
11/12/2012
-
MethylGene Announces $26.1 Million Private Placement
11/12/2012
-
MethylGene Presents MGCD265 Data at the 24th European Organization for Research and Treatment of Cancer-National Cancer Institute-American Association for Cancer Research Symposium on Molecular Targets and Cancer Therapeutics
11/8/2012